154 related articles for article (PubMed ID: 25497409)
1. Hereditary breast and ovarian cancer syndrome: considering the complexities.
Senter L
Curr Probl Cancer; 2014; 38(6):226-34. PubMed ID: 25497409
[TBL] [Abstract][Full Text] [Related]
2. Beyond BRCA1 and BRCA2.
King-Spohn K; Pilarski R
Curr Probl Cancer; 2014; 38(6):235-48. PubMed ID: 25497410
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.
Meaney-Delman D; Bellcross CA
Obstet Gynecol Clin North Am; 2013 Sep; 40(3):475-512. PubMed ID: 24021253
[TBL] [Abstract][Full Text] [Related]
4. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
5. The changing landscape of genetic testing for hereditary breast and ovarian cancer.
Bellcross CA
Curr Probl Cancer; 2014; 38(6):209-15. PubMed ID: 25497408
[No Abstract] [Full Text] [Related]
6. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
[TBL] [Abstract][Full Text] [Related]
7. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
Stuckey AR; Onstad MA
Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
[TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
9. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
Szender JB; Kaur J; Clayback K; Hutton ML; Mikkelson J; Odunsi K; Dresbold C
Int J Gynecol Cancer; 2018 Jan; 28(1):26-33. PubMed ID: 28930807
[TBL] [Abstract][Full Text] [Related]
10. Practical aspects of genetic counseling in breast cancer: lights and shadows.
Christinat A; Pagani O
Breast; 2013 Aug; 22(4):375-82. PubMed ID: 23673076
[TBL] [Abstract][Full Text] [Related]
11. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Staudigl C; Pfeiler G; Hrauda K; Renz R; Berger A; Lichtenschopf R; Singer CF; Tea MK
BMC Cancer; 2016 Jul; 16():436. PubMed ID: 27391110
[TBL] [Abstract][Full Text] [Related]
12. Managing families with a hereditary cancer syndrome.
Mahon SM
Oncol Nurs Forum; 2011 Nov; 38(6):641-4. PubMed ID: 22037327
[No Abstract] [Full Text] [Related]
13. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
Bando H
Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
[TBL] [Abstract][Full Text] [Related]
14. Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications.
Snyder C
Fam Cancer; 2016 Jul; 15(3):493-6. PubMed ID: 26920353
[TBL] [Abstract][Full Text] [Related]
15. "Second-Class Status?" Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome.
Suttman A; Pilarski R; Agnese DM; Senter L
J Genet Couns; 2018 Aug; 27(4):885-893. PubMed ID: 29404823
[TBL] [Abstract][Full Text] [Related]
16. Beyond BRCA: A Case Series Examining the Advent of Multigene Panel Testing.
Reap L; Ahsan S; Saleh M
Clin Breast Cancer; 2018 Aug; 18(4):e431-e439. PubMed ID: 29739691
[No Abstract] [Full Text] [Related]
17. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
18. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome.
Werner-Lin A; Ratner R; Hoskins LM; Lieber C
J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978
[TBL] [Abstract][Full Text] [Related]
19. [Genetic Counseling of HBOC and Japanese Organization of HBOC].
Fukushima Y
Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668
[TBL] [Abstract][Full Text] [Related]
20. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
